Zenara Pharma receives DCGI approval to manufacture, sell Favipiravir tablets

Image Source : SOCIAL MEDIA Zenara Pharma receives DCGI approval to manufacture, sell Favipiravir tablets Zenara Pharma, a fully owned subsidiary of Biophore India Pharmaceuticals, announced that it has received approval from the Drugs Controller General of India (DCGI), to manufacture and sell Favipiravir tablets as a treatment option for…

Read More Zenara Pharma receives DCGI approval to manufacture, sell Favipiravir tablets

Serum Institute asked to revise protocol to conduct Oxford’s coronavirus vaccine Phase 2, 3 human trials

Image Source : AP Serum Institute of India has been asked by DCGI to revise its protocol to conduct Oxford’s coronavirus vaccine Phase 2, 3 human trials in India. Serum Institute of India (SII), who earlier sought permission to conduct Phase-2 and 3 trials of Oxford University’s coronavirus vaccine in…

Read More Serum Institute asked to revise protocol to conduct Oxford’s coronavirus vaccine Phase 2, 3 human trials

Cipla gets nod to launch affordable Favipiravir in India for treatment of COVID-19 patients

Image Source : EUROPEAN PHARMA REVIEW Cipla gets nod to launch affordable Favipiravir in India for treatment of COVID-19 patients  Pharmaceutical firm Cipla is set to launch COVID-19 drug Favipiravir, developed by the Council of Scientific and Industrial Research (CSIR) in a cost-effective process, stated an official statement. “Cipla has…

Read More Cipla gets nod to launch affordable Favipiravir in India for treatment of COVID-19 patients

FabiFlu: All you need to know about Glenmark’s COVID-19 treatment medicine

Image Source : FILE FabiFlu: All you need to know about Glenmark’s COVID-19 treatment medicine Drug major Glenmark Pharmaceuticals has become the first Indian company to commercially launch an antiviral drug for the treatment of mild to moderate COVID-19 patients, after it received the Indian drug regulator Drug Controller General…

Read More FabiFlu: All you need to know about Glenmark’s COVID-19 treatment medicine